DE602005024021D1 - GEN ANLN IN VERBINDUNG MIT NICHT-KLEINZELLIGEM LUNGENKREBS UND SEINE WECHSELWIRKUNGEN MIT RhoA - Google Patents
GEN ANLN IN VERBINDUNG MIT NICHT-KLEINZELLIGEM LUNGENKREBS UND SEINE WECHSELWIRKUNGEN MIT RhoAInfo
- Publication number
- DE602005024021D1 DE602005024021D1 DE602005024021T DE602005024021T DE602005024021D1 DE 602005024021 D1 DE602005024021 D1 DE 602005024021D1 DE 602005024021 T DE602005024021 T DE 602005024021T DE 602005024021 T DE602005024021 T DE 602005024021T DE 602005024021 D1 DE602005024021 D1 DE 602005024021D1
- Authority
- DE
- Germany
- Prior art keywords
- cancer
- anln
- rhoa
- interaction
- small cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/82—Translation products from oncogenes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60056104P | 2004-08-10 | 2004-08-10 | |
PCT/JP2005/014887 WO2006016697A1 (en) | 2004-08-10 | 2005-08-09 | Non-small cell lung cancer-related gene, anln, and its interactions with rhoa |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005024021D1 true DE602005024021D1 (de) | 2010-11-18 |
Family
ID=35355888
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005024021T Active DE602005024021D1 (de) | 2004-08-10 | 2005-08-09 | GEN ANLN IN VERBINDUNG MIT NICHT-KLEINZELLIGEM LUNGENKREBS UND SEINE WECHSELWIRKUNGEN MIT RhoA |
Country Status (6)
Country | Link |
---|---|
US (1) | US20090297500A1 (de) |
EP (1) | EP1787122B1 (de) |
JP (1) | JP4874234B2 (de) |
AT (1) | ATE483979T1 (de) |
DE (1) | DE602005024021D1 (de) |
WO (1) | WO2006016697A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8131476B2 (en) | 2006-08-07 | 2012-03-06 | General Electric Company | System and method for co-registering multi-channel images of a tissue micro array |
US8060348B2 (en) | 2006-08-07 | 2011-11-15 | General Electric Company | Systems for analyzing tissue samples |
WO2008063413A2 (en) | 2006-11-13 | 2008-05-29 | Source Precision Medicine, Inc. | Gene expression profiling for identification, monitoring, and treatment of lung cancer |
US20100184047A1 (en) * | 2007-03-30 | 2010-07-22 | Oncotherapy Science, Inc. | Screening and therapeutic method for nsclc targeting the cdca8-aurkb complex |
EP2161577A1 (de) * | 2008-09-01 | 2010-03-10 | Atlas Antibodies AB | ANLN-Protein |
US20120041274A1 (en) | 2010-01-07 | 2012-02-16 | Myriad Genetics, Incorporated | Cancer biomarkers |
US9125899B1 (en) | 2010-06-17 | 2015-09-08 | Stc.Unm | Modulators of GTPases and their use |
US20120053253A1 (en) * | 2010-07-07 | 2012-03-01 | Myriad Genetics, Incorporated | Gene signatures for cancer prognosis |
BR112012032537B8 (pt) | 2010-07-09 | 2022-10-18 | Somalogic Inc | Métodos para diagnosticar se um indivíduo tem ou não câncer de pulmão de não pequenas células, ou para fornecer informações sobre câncer de pulmão de não pequenas células em um indivíduo |
US9605319B2 (en) | 2010-08-30 | 2017-03-28 | Myriad Genetics, Inc. | Gene signatures for cancer diagnosis and prognosis |
JP6127972B2 (ja) | 2011-09-09 | 2017-05-17 | コニカミノルタ株式会社 | 組織染色方法 |
SG11201400375SA (en) * | 2011-10-24 | 2014-04-28 | Somalogic Inc | Lung cancer biomarkers and uses thereof |
JP5806168B2 (ja) * | 2012-06-19 | 2015-11-10 | 国立大学法人 岡山大学 | 抗浸潤薬の新規スクリーニング法 |
ES2938766T3 (es) | 2012-11-16 | 2023-04-14 | Myriad Genetics Inc | Firmas génicas para el pronóstico de cáncer |
EP3143160B1 (de) | 2014-05-13 | 2019-11-06 | Myriad Genetics, Inc. | Gensignaturen für krebsprognosen |
US10870854B2 (en) | 2016-06-09 | 2020-12-22 | The Board Of Regents Of The University Of Texas System | Inhibitory RNA-based therapeutics targeting ANLN for cancer treatment |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200413725A (en) * | 2002-09-30 | 2004-08-01 | Oncotherapy Science Inc | Method for diagnosing non-small cell lung cancers |
WO2004091548A2 (en) * | 2003-04-15 | 2004-10-28 | Avalon Pharmaceuticals, Inc | Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods |
-
2005
- 2005-08-09 DE DE602005024021T patent/DE602005024021D1/de active Active
- 2005-08-09 AT AT05770407T patent/ATE483979T1/de not_active IP Right Cessation
- 2005-08-09 WO PCT/JP2005/014887 patent/WO2006016697A1/en active Application Filing
- 2005-08-09 JP JP2007506605A patent/JP4874234B2/ja not_active Expired - Fee Related
- 2005-08-09 EP EP05770407A patent/EP1787122B1/de not_active Not-in-force
- 2005-08-09 US US11/573,393 patent/US20090297500A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1787122A1 (de) | 2007-05-23 |
WO2006016697A1 (en) | 2006-02-16 |
JP4874234B2 (ja) | 2012-02-15 |
ATE483979T1 (de) | 2010-10-15 |
EP1787122B1 (de) | 2010-10-06 |
US20090297500A1 (en) | 2009-12-03 |
JP2008510126A (ja) | 2008-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005024021D1 (de) | GEN ANLN IN VERBINDUNG MIT NICHT-KLEINZELLIGEM LUNGENKREBS UND SEINE WECHSELWIRKUNGEN MIT RhoA | |
MX2020012204A (es) | Inhibidores de kras g12c para tratar el cáncer. | |
MX2020012731A (es) | Inhibidores de kras g12c y metodos para su uso. | |
CY1118612T1 (el) | Μεθοδοι και χημικες συνθεσεις για την θεραπευτικη αντιμετωπιση των εμμενουσων λοιμωξεων και του καρκινου μεσω αναστολης της οδου προγραμματισμενου κυτταρικου θανατου 1 (pd-1) | |
WO2009049214A3 (en) | Inhibition and treatment of prostate cancer metastasis | |
TW200716141A (en) | Compositions and methods for treatment for neoplasms | |
ATE422162T1 (de) | Verfahren zur vorhersage und verhinderung der resistenz gegen taxoid-verbindungen | |
PT1893196E (pt) | Composto de diaril-hidantoína | |
WO2007053573A3 (en) | Treatment of cancer with sorafenib | |
TW200600785A (en) | Method for diagnosing non-small cell lung cancer | |
CY1108092T1 (el) | Ενωσεις και μεθοδοι για την αναστολη της μιτωτικης προοδου με την αναστολη της κινασης aurora | |
EP2298304A3 (de) | Zur Krebsbehandlung nützliche Carbolinderivate | |
WO2007081720A3 (en) | Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer | |
ATE393240T1 (de) | Verfahren zum nachweis von prostatakrebs | |
ATE404574T1 (de) | Verfahren zur inhibierung der proliferation von tumorzellen, bei dem platinkomplexe eingesetzt werden | |
MX2009006627A (es) | Quinazolinas para la inhibicion de pdk1. | |
DK1951759T3 (da) | Anti-EGFR-antistoffer | |
MX2007006640A (es) | Biomarcadores para la preseleccion de pacientes para la terapia con anti-receptor 1 del factor de crecimiento similar a la insulina. | |
ATE554769T1 (de) | Neuromuskuläre blocker mit mittlerer dauer und antagonisten advon | |
WO2010042933A3 (en) | Inhibition and treatment of prostate cancer metastasis | |
WO2006086772A3 (en) | DIAGNOSING AND TREATING CANCER USING β-CATENIN SPLICE VARIANTS | |
MX2018000598A (es) | Fragmentos de anticuerpos radiomarcados para uso en tratamiento de cancer. | |
DE602005026962D1 (de) | Arylcarboxamide und ihre verwendung als antitumormittel | |
WO2023004342A3 (en) | Methods for identifying adar1 inhibitors, and compositions and methods of use in treating cancer | |
TW200605885A (en) | Multicyclic lonidamine analogs |